JP2021525787A5 - - Google Patents

Info

Publication number
JP2021525787A5
JP2021525787A5 JP2020568390A JP2020568390A JP2021525787A5 JP 2021525787 A5 JP2021525787 A5 JP 2021525787A5 JP 2020568390 A JP2020568390 A JP 2020568390A JP 2020568390 A JP2020568390 A JP 2020568390A JP 2021525787 A5 JP2021525787 A5 JP 2021525787A5
Authority
JP
Japan
Prior art keywords
approximately
hour
pharmaceutical composition
days
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020568390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525787A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/065016 external-priority patent/WO2019234240A1/en
Publication of JP2021525787A publication Critical patent/JP2021525787A/ja
Publication of JP2021525787A5 publication Critical patent/JP2021525787A5/ja
Priority to JP2024075901A priority Critical patent/JP2024107004A/ja
Pending legal-status Critical Current

Links

JP2020568390A 2018-06-07 2019-06-07 β−ラクタム化合物とプロベネシドの組み合わせとその使用 Pending JP2021525787A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075901A JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862682116P 2018-06-07 2018-06-07
US62/682,116 2018-06-07
US201962804970P 2019-02-13 2019-02-13
US62/804,970 2019-02-13
PCT/EP2019/065016 WO2019234240A1 (en) 2018-06-07 2019-06-07 Combinations of beta-lactam compounds and probenecid and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075901A Division JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Publications (2)

Publication Number Publication Date
JP2021525787A JP2021525787A (ja) 2021-09-27
JP2021525787A5 true JP2021525787A5 (enExample) 2022-06-15

Family

ID=67105981

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020568390A Pending JP2021525787A (ja) 2018-06-07 2019-06-07 β−ラクタム化合物とプロベネシドの組み合わせとその使用
JP2024075901A Pending JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075901A Pending JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Country Status (8)

Country Link
US (3) US11554112B2 (enExample)
EP (1) EP3801486A1 (enExample)
JP (2) JP2021525787A (enExample)
CN (2) CN118903120A (enExample)
AU (1) AU2019281018B2 (enExample)
BR (1) BR112020024498A2 (enExample)
TW (1) TW202005970A (enExample)
WO (1) WO2019234240A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EP3790535A1 (en) 2019-02-13 2021-03-17 Iterum Therapeutics International Limited Combinations of beta-lactam compounds and probenecid and uses thereof
CA3169900A1 (en) * 2020-03-11 2021-09-16 Iterum Therapeutics International Limited Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof
EP4132503B1 (en) * 2020-04-10 2026-04-22 University of Georgia Research Foundation, Inc. Probenecid for use in the treatment of sars-co-v2 infections
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN112076161B (zh) * 2020-08-07 2022-10-18 安徽康正康仁药业有限公司 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂
CN111840236B (zh) * 2020-08-07 2022-09-02 安徽康正康仁药业有限公司 一种注射用美罗培南丙磺舒钠复方冻干制剂
CN111821462A (zh) * 2020-08-07 2020-10-27 安徽康正康仁药业有限公司 青霉素类钠盐与丙磺舒钠组成的复方冻干制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3302335A1 (de) * 1982-01-26 1983-07-28 Leo Pharmaceutical Products Ltd. A/S (Loevens kemiske Fabrik Produktionsaktieselskab), 2750 Ballerup Ss-lactamverbindungen, ihre herstellung und sie enthaltendes arzneimittel
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
UA59394C2 (uk) 1998-03-27 2003-09-15 Каділа Фармацевтікелс (І.Ей) Лтд. Стійка у фіксованих дозах оральна фармацевтична композиція, що містить антибактеріальний засіб і мікроорганізм одночасно, та спосіб її одержання (варіанти)
ATE266407T1 (de) 2000-10-30 2004-05-15 Lupin Ltd Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
AU2001227030A1 (en) 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
ATE319434T1 (de) 2001-11-19 2006-03-15 Lupin Ltd Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam- antibiotikums
CN1853724A (zh) 2004-12-01 2006-11-01 吴晓辉 丙磺舒钠、钾与β－内酰胺类抗生素组成复方针剂及其用途
CN1813700A (zh) 2006-03-01 2006-08-09 吴晓辉 丙磺舒钠与青霉素类抗生素组成复方针剂
ES2355950T3 (es) * 2006-06-28 2011-04-01 Pfizer Products Inc. Profármacos de penem.
PE20080940A1 (es) 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
ES2689107T3 (es) 2009-11-13 2018-11-08 Astrazeneca Ab Formulaciones de tabletas bicapa
JP2016512817A (ja) 2013-03-15 2016-05-09 ヤンセン ファーマシューティカ エヌ．ベー． 高尿酸血症の治療におけるカナグリフロジンとプロベネシドの組合せ
TR201605632A1 (tr) 2016-04-28 2017-11-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EP3790535A1 (en) 2019-02-13 2021-03-17 Iterum Therapeutics International Limited Combinations of beta-lactam compounds and probenecid and uses thereof
CA3169900A1 (en) 2020-03-11 2021-09-16 Iterum Therapeutics International Limited Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

Similar Documents

Publication Publication Date Title
JP2021525787A5 (enExample)
JP6875454B2 (ja) Ｈｉｖを治療するためのトール様受容体の調節因子
JP5468015B2 (ja) 抗菌ペプチド系に対する作動薬
JP2022511732A5 (enExample)
JP2007523049A (ja) 高脂血症治療剤
JP2015512406A5 (enExample)
JP2011502997A5 (enExample)
US10363235B2 (en) Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
JP2005537238A (ja) ポリヒドロキシアルカンの脂肪酸エステルおよびピリジンカルボキシ誘導体の新規複合体
JP2017513824A5 (enExample)
CN113164420A (zh) 治疗组合物
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
JP2022503733A5 (enExample)
RU2007107935A (ru) Полисульфатированные гликозиды и их соли
WO2020117755A1 (en) Compositions and methods for treating biofilms
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
JP2019521178A5 (enExample)
JP2008088189A5 (enExample)
JP2023531930A5 (enExample)
JP2021107447A5 (enExample)
JP2022518288A5 (enExample)
BR112021005955A2 (pt) agentes e métodos para modular atividade de patógeno
JP2005509663A5 (enExample)
US20050227949A1 (en) Compositions and methods for treatment of viral and bacterial infections
JP4380967B2 (ja) ウイルス性心筋炎の予防または治療剤